Outlook Therapeutics, Inc. (OTLK) Net Income (Loss) Attributable to Parent USD 2015 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Outlook Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2015 to 2024.
  • Outlook Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$114 M, a 1618% decline year-over-year.
  • Outlook Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$159 M, a 178% decline year-over-year.
  • Outlook Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$59 M, a 10.7% increase from 2022.
  • Outlook Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$66.1 M, a 24.2% decline from 2021.
  • Outlook Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$53.2 M, a 50.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$159 M -$114 M -$108 M -1618% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$51.5 M -$11.2 M +$7.48 M +40.1% Oct 1, 2023 Dec 31, 2023 10-Q 2024-05-15
Q3 2023 -$59 M -$13 M +$1.35 M +9.44% Jul 1, 2023 Sep 30, 2023 10-K 2023-12-22
Q2 2023 -$60.3 M -$20.7 M -$3.14 M -17.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$57.2 M -$6.65 M +$13.1 M +66.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$70.3 M -$18.7 M -$4.2 M -29% Oct 1, 2022 Dec 31, 2022 10-Q 2024-05-15
Q3 2022 -$66.1 M -$14.3 M -$941 K -7.02% Jul 1, 2022 Sep 30, 2022 10-K 2023-12-22
Q2 2022 -$65.1 M -$17.5 M -$5.34 M -43.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$59.8 M -$19.7 M -$6.6 M -50.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-08-14
Q4 2021 -$53.2 M -$14.5 M -$6.82 K -0.05% Oct 1, 2021 Dec 31, 2021 10-Q 2023-08-14
Q3 2021 -$53.2 M -$13.4 M -$3.48 M -35.1% Jul 1, 2021 Sep 30, 2021 10-K 2022-12-29
Q2 2021 -$49.7 M -$12.2 M -$9.18 M -305% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$40.5 M -$13.1 M -$7.41 M -130% Jan 1, 2021 Mar 31, 2021 10-Q 2022-08-10
Q4 2020 -$33.1 M -$14.5 M +$2.15 M +12.9% Oct 1, 2020 Dec 31, 2020 10-Q 2022-08-10
Q3 2020 -$35.2 M -$9.92 M +$175 K +1.73% Jul 1, 2020 Sep 30, 2020 10-K 2021-12-23
Q2 2020 -$35.4 M -$3.01 M +$1.43 M +32.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$36.8 M -$5.7 M +$4.54 M +44.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$41.4 M -$16.6 M -$6.86 M -70.4% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-16
Q3 2019 -$34.5 M -$10.1 M +$2.1 M +17.2% Jul 1, 2019 Sep 30, 2019 10-K 2020-12-23
Q2 2019 -$36.6 M -$4.44 M +$3.99 M +47.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$40.6 M -$10.2 M -$2.7 M -35.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$37.9 M -$9.74 M -$7.82 M -407% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-14
Q3 2018 -$30.1 M -$12.2 M -$5.83 M -91.4% Jul 1, 2018 Sep 30, 2018 10-K 2019-12-19
Q2 2018 -$24.3 M -$8.43 M -$3.1 M -58.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$21.2 M -$7.54 M +$506 K +6.29% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$21.7 M -$1.92 M +$17.2 M +89.9% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-14
Q3 2017 -$38.8 M -$6.37 M +$4.19 M +39.7% Jul 1, 2017 Sep 30, 2017 10-K 2018-12-18
Q2 2017 -$43 M -$5.33 M +$17 M +76.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$60 M -$8.05 M -$4.5 M -127% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$55.5 M -$19.1 M -$2.23 M -13.2% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-14
Q3 2016 -$53.3 M -$10.6 M Jul 1, 2016 Sep 30, 2016 10-K 2017-12-29
Q2 2016 -$22.3 M -$11 M -96.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$3.54 M +$10.4 M +74.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$16.9 M Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-14
Q2 2015 -$11.3 M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$14 M Jan 1, 2015 Mar 31, 2015 10-Q 2016-06-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.